Cargando…

Real-World Treatment of Patients Newly Diagnosed with Chronic Obstructive Pulmonary Disease: A Retrospective German Claims Data Analysis

PURPOSE: This study aimed to describe the real-world treatment of German incident COPD patients, compare that treatment with clinical guidelines, and provide insight into disease development after incident diagnosis. In addition, the economic burden of the disease by assessing COPD-related healthcar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Buhl, Roland, Wilke, Thomas, Picker, Nils, Schmidt, Olaf, Hechtner, Marlene, Kondla, Anke, Maywald, Ulf, Vogelmeier, Claus F
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9512029/ https://www.ncbi.nlm.nih.gov/pubmed/36172035 http://dx.doi.org/10.2147/COPD.S375190

Ejemplares similares

Liver disease epidemiology and burden in patients with alterations in plasma protein metabolism: German retrospective insurance claims analysis
por: Picker, Nils, et al.
Publicado: (2023)

A Non-Interventional Study of Tiotropium/Olodaterol versus Any Triple Combination Therapy for Chronic Obstructive Pulmonary Disease: The EVELUT(®) Study Protocol
por: Buhl, Roland, et al.
Publicado: (2020)

Epidemiology, healthcare utilization, and related costs among patients with IPF: results from a German claims database analysis
por: Kreuter, Michael, et al.
Publicado: (2022)

Evaluating the Economic Burden of Relapses in Neuromyelitis Optica Spectrum Disorder: A Real-World Analysis Using German Claims Data
por: Knapp, Rachel K., et al.
Publicado: (2021)

EPH144 The Impact of COVID-19 Pandemic on the Detection and Management of Cancer: A German Claims Data Analysis
por: Mevius, A, et al.
Publicado: (2022)

POSA52 A Year-on-Year Comparison Overall German Healthcare Resource Utilization in COVID Versus Non-COVID Times: A German Claims Data Analysis
por: Mevius, A, et al.
Publicado: (2022)

Real-world treatment of German patients with recurrent and advanced endometrial cancer with a post-platinum treatment: a retrospective claims data analysis
por: Mevius, Antje, et al.
Publicado: (2022)

P21 Social Distancing and Trends in Influenza Hospitalization during the COVID-19 Outbreak: A Difference-in-Difference Analysis of German Claims Data
por: Pacis, S, et al.
Publicado: (2022)

Identifying the Causes Increasing the Risk of Non-Adherence in Adult Patients with Asthma: An Analysis Combining Patient Survey Data with German Claims Data
por: Müller, Sabrina, et al.
Publicado: (2021)

Inadequate Response, Treatment Patterns, Health Care Utilization, and Associated Costs in Patients With Ulcerative Colitis: Retrospective Cohort Study Based on German Claims Data
por: Bokemeyer, Bernd, et al.
Publicado: (2022)

Outcome measures in chronic obstructive pulmonary disease (COPD): strengths and limitations
por: Glaab, Thomas, et al.
Publicado: (2010)

Real-world effectiveness and safety of oral anticoagulation strategies in atrial fibrillation: a cohort study based on a German claims dataset
por: Mueller, Sabrina, et al.
Publicado: (2018)

Assessment of physical functioning and handling of tiotropium/olodaterol Respimat(®) in patients with COPD in a real-world clinical setting
por: Steinmetz, Karl-Otto, et al.
Publicado: (2019)

A year in the life of German patients with COPD: the DACCORD observational study
por: Buhl, Roland, et al.
Publicado: (2016)

Guideline Adherence and Associated Outcomes in the Treatment of Type 2 Diabetes Mellitus Patients With an Incident Cardiovascular Comorbidity: An Analysis Based on a Large German Claims Dataset
por: Gabler, Maximilian, et al.
Publicado: (2021)

Real-world outcomes associated with switching to anti-TNFs versus other biologics in Crohn’s Disease patients: A retrospective analysis using German claims data
por: Zhuleku, Evi, et al.
Publicado: (2022)

Real-world treatment and survival of patients with advanced non-small cell lung Cancer: a German retrospective data analysis
por: Hardtstock, Fränce, et al.
Publicado: (2020)

Epidemiology and treatment of patients with Chronic rhinosinusitis with nasal polyps in Germany—A claims data study
por: Starry, Alexandra, et al.
Publicado: (2022)

Non-persistence and non-adherence to MTX therapy in patients with rheumatoid arthritis: a retrospective cohort study based on German RA patients
por: Müller, Sabrina, et al.
Publicado: (2017)

Real-world insulin therapy in German type 2 diabetes mellitus patients: patient characteristics, treatment patterns, and insulin dosage
por: Wilke, Thomas, et al.
Publicado: (2019)

Guideline-based survey of outpatient COPD management by pulmonary specialists in Germany
por: Glaab, Thomas, et al.
Publicado: (2012)

Poststroke epilepsy incidence, risk factors and treatment: German claims analysis
por: Hardtstock, Fränce, et al.
Publicado: (2021)

Costs and Clinical Consequences of Compliance with COPD GOLD Recommendations or National Guidelines Compared with Current Clinical Practice in Belgium, Germany, Sweden, and the United States
por: Sethi, Sanjay, et al.
Publicado: (2022)

Evaluating student’s ability to assess treatment claims: validating a German version of the Claim Evaluation Tools
por: Hinneburg, Jana, et al.
Publicado: (2023)

Impact of switching from triple therapy to dual bronchodilation in COPD: the DACCORD ‘real world’ study
por: Vogelmeier, Claus F., et al.
Publicado: (2022)

In ‘real world’ patients with COPD, exacerbation history, and not blood eosinophils, is the most reliable predictor of future exacerbations
por: Worth, Heinrich, et al.
Publicado: (2023)

Healthcare Resource Utilization and Associated Costs in New Users of Empagliflozin versus DPP-4 Inhibitors and GLP-1 Agonists: A Comparative Analysis Based on Retrospective Real-World Data from German Sickness Funds
por: Wilke, Thomas, et al.
Publicado: (2022)

EE391 Impact of the COVID-19 Pandemic on the Healthcare Resource Use of People With Newly Diagnosed Mood/Affective Disorder
por: Junker, S, et al.
Publicado: (2022)

The Prospective Non-Interventional DACCORD Study in the National COPD Registry in Germany: design and methods
por: Kardos, Peter, et al.
Publicado: (2015)

The Best Methods for Newly Claimed Areas
Publicado: (1921)

Osteoporotic fractures and subsequent fractures: imminent fracture risk from an analysis of German real-world claims data
por: Hadji, Peyman, et al.
Publicado: (2021)

Chronisch-obstruktive Lungenerkrankung 2021 – die richtige Therapie für den richtigen Patienten
por: Olschewski, Horst, et al.
Publicado: (2021)

Lung Health for All: Chronic Obstructive Lung Disease and World Lung Day 2022
por: Halpin, David M. G., et al.
Publicado: (2022)

Early cardiovascular abnormalities in newly diagnosed obstructive sleep apnea
por: Baguet, Jean-Philippe, et al.
Publicado: (2009)

EVELUT®: A Real-World, Observational Study Assessing Dyspnoea and Symptom Burden in COPD Patients Switched from LABA/ICS to LAMA/LABA or LAMA/LABA/ICS
por: Buhl, Roland, et al.
Publicado: (2023)

Burden of disease among patients with prevalent Crohn’s disease: results from a large German sickness fund
por: Zhuleku, Evi, et al.
Publicado: (2023)

To diagnose or not to diagnose your BPD patient
por: De Picker, L.
Publicado: (2021)

The Clinical and Economic Burden of Newly Diagnosed Hereditary Transthyretin (ATTRv) Amyloidosis: A Retrospective Analysis of Claims Data
por: Reddy, Sheila R., et al.
Publicado: (2020)

COPD Assessment Test Changes from Baseline Correlate with COPD Exacerbations: A Longitudinal Analysis of the DACCORD Observational Study
por: Kardos, Peter, et al.
Publicado: (2020)

Impact of Lung Function and Exacerbations on Health-Related Quality of Life in COPD Patients Within One Year: Real-World Analysis Based on Claims Data
por: Stöber, Alisa, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pr0b63dr3d5sjmrvbgq86bc3o8